Diabetes and Endocrinology

Latest News

Sanofi Slashes Lantus List Price by 78%
Sanofi Slashes Lantus List Price by 78%

March 18th 2023

The company also will establish a $35 cap on out-of-pocket costs for Lantus for all patients with commercial insurance.

Novo Nordisk Cuts Price on Several Insulin Products by 75%
Novo Nordisk Cuts Price on Several Insulin Products by 75%

March 14th 2023

FDA Accepts sNDA for Jardiance in Children 10 to 17 with Diabetes
FDA Accepts sNDA for Jardiance in Children 10 to 17 with Diabetes

March 8th 2023

Updated: Lilly Cuts Prices of Some Insulins and Caps Out-of-Pocket Costs
Updated: Lilly Cuts Prices of Some Insulins and Caps Out-of-Pocket Costs

March 2nd 2023

FDA Approves New Drug for Type 2 Diabetes
FDA Approves New Drug for Type 2 Diabetes

January 23rd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.